Related Experiment Video
Updated: Jan 23, 2026

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
Viral Bacterial Interactions in Children: Impact on Clinical Outcomes
Alejandro Diaz-Diaz1,2, Cristina Garcia-Maurino2, Alejandro Jordan-Villegas3
1From the Department of Pediatrics, Division of Pediatric Infectious Diseases, Nationwide Children's Hospital-The Ohio State University College of Medicine, Columbus, OH.
Insights
Respiratory syncytial virus (RSV) causes severe respiratory illness in young children. The upper respiratory tract microbiome may influence RSV disease severity, impacting how children respond to infection.
Area of Science:
- Pediatrics
- Infectious Diseases
- Microbiology
Background:
- Respiratory viral infections, particularly respiratory syncytial virus (RSV), are a major cause of illness and death in children globally.
- While certain groups are at higher risk, most children hospitalized for RSV are otherwise healthy.
- The precise mechanisms behind the varied clinical presentations of RSV disease remain unclear.
Purpose of the Study:
- To review the current evidence on the relationship between the respiratory microbiome and respiratory syncytial virus (RSV) disease severity.
- To explore the epidemiologic links and mechanisms of viral-bacterial interactions in RSV infection.
- To understand how the upper respiratory tract microbiome influences the pathogenesis and clinical outcomes of RSV in young children.
Main Methods:
- Literature review of existing studies on respiratory syncytial virus (RSV).
- Analysis of research on viral-bacterial interactions.
- Examination of the association between the upper respiratory tract microbiome and disease severity.
Main Results:
- The complex interplay between the respiratory microbiome, host immunity, and RSV is increasingly recognized as a factor in disease severity.
- Evidence suggests a link between specific microbial profiles and the clinical outcomes of RSV infection.
- Mechanisms of viral-bacterial interactions are being investigated for their role in RSV pathogenesis.
Conclusions:
- The upper respiratory tract microbiome is a potential modulator of respiratory syncytial virus (RSV) disease severity in children.
- Further research into the microbiome's role could reveal new therapeutic targets for preventing severe RSV outcomes.
- Understanding these interactions is crucial for explaining the variability in clinical presentations of RSV infection.
Abstract:
Respiratory viral infections are associated with significant morbidity and mortality in children < 5 years of age worldwide. Among all respiratory viruses, respiratory syncytial virus (RSV) is the world's leading cause of bronchiolitis and pneumonia in young children. There are known populations at risk for severe disease but the majority of children who require hospitalization for RSV infection are previously healthy. Viral and host factors have been associated with the pathogenesis of RSV disease; however, the mechanisms that explain the wide variability in the clinical presentation are not completely understood. Recent studies suggest that the complex interaction between the respiratory microbiome, the host's immune response and the virus may have an impact on the pathogenesis and severity of RSV infection. In this review, we summarize the current evidence regarding the epidemiologic link, the mechanisms of viral-bacterial interactions, and the associations between the upper respiratory tract microbiome and RSV disease severity.
Related Concept Videos
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Predicting Reaction Outcomes
Viral Recombination
Viral Structure
Impact of Groups on Groups
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...

